Jazz Pharmaceuticals (JAZZ) SEC Filings & 10K Form

$108.32
-1.35 (-1.23%)
(As of 04/24/2024 ET)

Recent Jazz Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/09/2024
3:39 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
5:07 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:49 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:53 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:44 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:47 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
8:48 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:09 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:54 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:58 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:28 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:32 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:34 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:44 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:47 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:50 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:52 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:11 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2024
6:14 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/01/2024
2:11 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
6:46 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:29 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/25/2024
4:01 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
01/19/2024
5:19 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:21 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:23 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:25 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:28 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:33 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:39 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
3:31 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
6:36 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
12:33 PM
Jazz Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
09/06/2023
4:09 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:39 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/31/2023
5:44 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Thousands of investors use this no cost solution | Do you? (Ad)

In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.

Simply tap here now to subscribe and start getting "Insider Financial Advantage"
08/29/2023
4:41 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
4:21 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:49 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
6:51 PM
Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:58 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:00 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:02 PM
Jazz Pharmaceuticals (Issuer)
Sohn Catherine A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:08 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:47 PM
Gray Peter (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:49 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:52 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:56 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:40 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2023
4:43 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:44 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
4:45 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
8:55 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:35 PM
Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:40 PM
Gray Peter (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:28 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:00 PM
Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:04 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:09 PM
Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:15 PM
Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
8:19 PM
Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:54 PM
Jazz Pharmaceuticals (Subject)
Sohn Catherine A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:36 PM
Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
5:41 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/22/2023
3:05 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
3:12 PM
Jazz Pharmaceuticals (Filer)
Form DEF 14A
06/12/2023
3:47 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
6:12 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/07/2023
6:15 PM
Jazz Pharmaceuticals (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
6:16 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
7:24 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
5:01 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2023
7:45 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
6:38 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2023
3:08 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:JAZZ) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners